Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Hematology Association
Pharma
EHA: Gearing up for US comeback, GSK details Blenrep's PFS win
If approved next month, the drug would complete a return to the U.S. market after it was withdrawn following a failed confirmatory study in 2022.
Zoey Becker
Jun 12, 2025 9:25am
Inconsistent survival data dent Roche's Columvi win in 2L DLBCL
Jun 16, 2024 5:32pm
J&J's Darzalex branches out beyond myeloma with amyloidosis win
Jun 13, 2020 2:30am
AbbVie, Roche cement Venclexta's place in AML with survival win
Jun 13, 2020 2:30am
